AI assistant
InspireMD, Inc. — Director's Dealing 2023
Mar 20, 2023
34187_dirs_2023-03-20_1b85877e-a5c0-4871-96f1-c344cff64ba7.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: InspireMD, Inc. (NSPR)
CIK: 0001433607
Period of Report: 2023-03-19
Reporting Person: Tommasoli Andrea (Chief Operating Officer)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 18103 | Direct |
| Common Stock | 59270 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Option to Purchase Common Stock | $5.25 | 2030-11-02 | Common Stock (6035) | Direct | |
| Option to Purchase Common Stock | $4.12 | 2031-10-13 | Common Stock (19756) | Direct |
Footnotes
F1: These shares of common stock represent shares of restricted stock, which vest and become exercisable in three equal annual installments, with 1/3 vesting on each of November 2, 2021, November 2, 2022 and November 2, 2023, subject to the Reporting Person's continued service.
F2: These shares of common stock represent shares of restricted stock, which vest and become exercisable in three equal annual installments, with 1/3 vesting on each of October 13, 2022, October 13, 2023 and October 13, 2024, subject to the Reporting Person's continued service.
F3: The options vest and become exercisable in three equal installments, with 1/3 vesting on each of November 2, 2021, November 2, 2022 and November 2, 2023, subject to the Reporting Person's continued service.
F4: The options vest and become exercisable in three equal installments, with 1/3 vesting on each of October 13, 2022, October 13, 2023 and October 13, 2024, subject to the Reporting Person's continued service.